Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06725927
PHASE4

Vaccination Against Influenza Pre-discharge in Heart Failure

Sponsor: Wroclaw Medical University

View on ClinicalTrials.gov

Summary

In patients with heart failure (HF), influenza vaccination should be considered to prevent HF hospitalizations. However, vaccination rates among patients with HF are low, in part because of subjective but common concerns about whether patients with such severe disease should be vaccinated. In this randomized, open-label study, we will investigate whether influenza vaccination before discharge in patients stabilized after cardiac decompensation is safe and improves outcomes over a 6-month follow-up period.

Official title: Vaccination Against Influenza Pre-discharge in Patients Hospitalized Due to Heart Failure

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2024-12-31

Completion Date

2025-12

Last Updated

2025-07-23

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

Influenza vaccination

Influenza vaccination pre-discharge in patients hospitalized due to heart failure exacerbation

Locations (1)

Jan Mikulicz Radecki University Hospital in Wroclaw

Wroclaw, Lower Silesian Voivodeship, Poland